Apellis Pharmaceuticals, Inc

(NASDAQ:APLS)

Latest On Apellis Pharmaceuticals, Inc (APLS):

Date/Time Type Description Signal Details
2023-05-25 17:48 ESTNewsApellis and Sobi to drop ALS candidate on Phase 2 setbackN/A
2023-05-18 17:01 ESTNewsApellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition SpaceN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals: Maintain 'Buy' Following Astellas' $5.9 Billion Acquisition Of Iveric BioN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.56 misses by $0.10, revenue of $44.84M beats by $18.74MN/A
2023-05-03 20:58 ESTNewsApellis Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-05-01 19:14 ESTNewsApellis weakness on Iveric Bio takeout is buying opportunity - analystN/A
2023-05-01 06:55 ESTNewsApellis Pharmaceuticals (APLS) Presents at the Association for Research in Vision and Ophthalmology Annual Meeting - SlideshowN/A
2023-04-03 17:26 ESTNewsApellis Pharmaceuticals may be worth $90-$100 a share in sale - analystN/A
2023-04-02 23:22 ESTNewsApellis Pharmaceuticals sees takeover interest from large pharma - BloombergN/A
2023-03-24 22:48 ESTNewsApellis Pharmaceuticals Is Poised For Dominance In Geographic Atrophy MarketN/A
2023-03-16 14:19 ESTNewsApellis Pharmaceuticals' Empaveli sNDA action date extended by FDAN/A
2023-02-23 11:44 ESTNewsApellis Pharmaceuticals prices $350M in stock offeringN/A
2023-02-22 09:58 ESTNewsApellis Pharmaceuticals to raise $300M in stock and warrants offeringN/A
2023-02-21 21:29 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.50 beats by $0.06, revenue of $22.66M misses by $1.86MN/A
2023-02-18 02:43 ESTNewsApellis wins FDA nod for eye disorder therapyN/A
2023-01-27 18:43 ESTNewsApellis: Empaveli Ought To Win Approval For Eye Disease In February - The Future Looks BrightN/A
2023-01-21 14:26 ESTNewsStocks To Watch: Earnings Heat Up, Healthcare Catalysts And M&A WildcardsN/A
2023-01-05 20:02 ESTNewsApellis appoints Baumal as Chief Medical OfficerN/A
2023-01-04 02:30 ESTNewsApellis, Arvinas lower as Wells Fargo downgrades in 2023 biotech previewN/A
2022-12-15 23:44 ESTNewsApellis Pharmaceuticals: Approval Is Baked Into ValuationN/A
2022-11-18 10:24 ESTNewsApellis surges 17% as FDA accepts to review new data in filing for eye disorder drugN/A
2022-11-11 06:07 ESTNewsApellis, IVERIC bio cut to Hold at Jefferies; says Street overestimates GA marketN/A
2022-11-08 08:01 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.75 misses by $0.29, revenue of $22.05M beats by $0.46MN/A
2022-11-08 08:00 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q3 2022 Earnings Call TranscriptN/A
2022-11-05 08:22 ESTNewsApellis Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-11-03 23:08 ESTNewsApellis sinks 20% as FDA review period for eye disease drug extendsN/A
2022-10-16 23:00 ESTNewsCiti lists four more value-creating events in biotech for this yearN/A
2022-09-29 06:33 ESTNewsApellis Pharmaceuticals: Trying To Develop A Blockbuster FranchiseN/A
2022-09-08 07:22 ESTNewsApellis gains as FDA says AdCom unnecessary for eye disease candidateN/A
2022-08-24 16:51 ESTNewsApellis stock dips amid 2-year data of pegcetacoplan for eye disorderN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 18:56 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.46 misses by $0.09, revenue of $16.32M misses by $0.63MN/A
2022-08-06 06:05 ESTNewsApellis Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-27 15:50 ESTNewsApellis to exchange $75.6M in convertible senior notes for common stockN/A
2022-07-20 18:36 ESTNewsApellis Pharmaceuticals: The Meaning Of Priority Review For Pegcetacoplan For Geographic AtrophyN/A
2022-07-20 03:57 ESTNewsWainwright sees blockbuster potential for Apellis eye degeneration therapy; shares up 22%N/A
2022-07-19 13:21 ESTNewsApellis stock soars 24% as FDA grants priority review to pegcetacoplan for eye disorderN/A
2022-07-19 13:19 ESTNewsH.C. Wainwright sees blockbuster potential for Apellis' treatment in eye degenerationN/A
2022-06-25 15:25 ESTNewsApellis: Mixed Data, But Definitely Approvable In GAN/A
2022-06-13 19:55 ESTNewsHot Stocks: APLS & SKIL both gain, TSLA declined despite upgrade, and VLTA plungedN/A
2022-06-10 11:34 ESTNewsApellis/Sobi Empaveli shows benefit in rare blood disorder patients in new analysesN/A
2022-06-01 11:05 ESTNewsApellis files for FDA approval of pegcetacoplan to treat eye disorderN/A
2022-05-06 19:17 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-06 19:15 ESTNewsApellis Pharmaceuticals (APLS) Investor Presentation - SlideshowN/A
2022-05-04 22:43 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.42 misses by $0.12, revenue of $12.1M misses by $0.52MN/A
2022-05-04 22:42 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 03:15 ESTNewsApellis Pharmaceuticals Q1 2022 Earnings PreviewN/A

About Apellis Pharmaceuticals, Inc (APLS):

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases; cold agglutinin disease; C3 glomerulopathy; and other glomerular diseases, such as IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company also develops APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for the prevention of immune system activation coincident with adeno-associated virus for intravenous administration, as well as is in Phase I/II clinical trial for acute respiratory distress syndrome. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) to co-develop pegcetacoplan. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

See Advanced Chart

General

  • Name Apellis Pharmaceuticals, Inc
  • Symbol APLS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 374
  • Fiscal Year EndDecember
  • IPO Date2017-11-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.apellis.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 13.99
  • Price/Book (Most Recent Quarter) 18.33
  • Enterprise Value Revenue 12.97
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.46
  • Next Year EPS Estimate -$5.31
  • Next Quarter EPS Estimate -$1.60
  • Profit Margin -138%
  • Operating Margin -85%
  • Return on Assets -20%
  • Return on Equity -289%
  • Revenue 250.65 million
  • Earnings Per Share -$3.32
  • Revenue Per Share $3.34
  • Gross Profit -74325000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 3.54 billion
  • Analyst Target Price $64.14
  • Book Value Per Share $2.69
View More

Share Statistics

  • Shares Outstanding 80.38 million
  • Shares Float 59.7 million
  • % Held by Insiders 2117%
  • % Held by Institutions 82.85%
  • Shares Short 8.11 million
  • Shares Short Prior Month 7.75 million
  • Short Ratio 13.44
  • Short % of Float 15%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.52
  • 52 Week High $58.47
  • 52 Week Low $21.84
  • 50 Day Moving Average 46.47
  • 200 Day Moving Average 42.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Apellis Pharmaceuticals, Inc (APLS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Apellis Pharmaceuticals, Inc (APLS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A$0.93-$0.45304.58%
2020-09-302020-11-02$646000-$1.79-$1.58-13.31%
2020-06-302020-07-30$N/A-$1.57-$1.34-17.56%
2020-03-312020-04-29$N/A-$2.29-$1.39-64.72%
2019-12-312020-02-27$N/A-$1.77-$1.14-55%
2019-09-302019-11-05$N/A-$1.10-$1.03-6.44%
2019-06-302019-07-31$N/A-$1.12-$0.78-44.39%
2019-03-312019-05-07$N/A-$0.87-$0.68-27.49%
2018-12-312019-02-26$N/A-$0.65-$0.707.58%
2018-09-302018-11-13$N/A-$0.64-$0.697.02%
2018-06-302018-07-31$N/A-$0.61-$0.42-45.86%
2018-03-312018-04-30$N/A-$0.43-$0.27-57.28%
2017-12-312018-03-19$N/A-$0.61-$0.27-129.32%
2017-09-302017-12-20$N/A-$0.23-$0.242.75%

Apellis Pharmaceuticals, Inc (APLS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Apellis Pharmaceuticals, Inc (APLS) Chart:

Apellis Pharmaceuticals, Inc (APLS) News:

Below you will find a list of latest news for Apellis Pharmaceuticals, Inc (APLS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Apellis Pharmaceuticals, Inc (APLS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-15100CALL0 0370.57TRUE00
2026-05-15110CALL0 0278.31TRUE00
2026-05-15120CALL0 0260.17TRUE00
2026-05-15130CALL0 0304.1TRUE00
2026-05-15140CALL0 0285.73TRUE00
2026-05-15150CALL0 0268.75TRUE00
2026-05-15160CALL0 0252.96TRUE00
2026-05-15170CALL0 0188.81TRUE00
2026-05-151822.91CALL0 15177.25TRUE00
2026-05-15190CALL0 4156.19TRUE00
2026-05-15200CALL0 2670TRUE00
2026-05-15210CALL0 0200.02TRUE00
2026-05-15220CALL0 2188.24TRUE00
2026-05-152317.85CALL0 840TRUE00
2026-05-15240CALL0 1040TRUE00
2026-05-15250CALL0 0155.83TRUE00
2026-05-15260CALL0 0145.84TRUE00
2026-05-15270CALL0 0133.06TRUE00
2026-05-15280CALL0 0123.86TRUE00
2026-05-15290CALL0 081.13TRUE00
2026-05-15300CALL0 074.21TRUE00
2026-05-15310CALL0 076.28TRUE00
2026-05-15320CALL0 094.18TRUE00
2026-05-15330CALL0 087.92TRUE00
2026-05-15340CALL0 077.44TRUE00
2026-05-15350CALL0 069.21TRUE00
2026-05-15360CALL0 153.39TRUE00
2026-05-15370CALL0 024.1TRUE00
2026-05-15380CALL0 00TRUE00
2026-05-15390CALL0 00TRUE00
2026-05-15401.05CALL0 1210TRUE00
2026-05-15410.05CALL20 40960FALSE00
2026-05-15420CALL0 133.12FALSE00
2026-05-15430CALL0 044.22FALSE00
2026-05-15440CALL0 051.93FALSE00
2026-05-15450.2CALL0 140.26FALSE00
2026-05-15460CALL0 065.52FALSE00
2026-05-15470CALL0 071.66FALSE00
2026-05-15480CALL0 077.47FALSE00
2026-05-15490CALL0 082.98FALSE00
2026-05-15500.05CALL0 136.17FALSE00
2026-05-15550CALL0 050.46FALSE00
2026-05-15600CALL0 062.95FALSE00
2026-05-15100PUT0 0223.3FALSE00
2026-05-15110PUT0 0208.66FALSE00
2026-05-15120PUT0 0195.36FALSE00
2026-05-15130PUT0 0183.16FALSE00
2026-05-15140PUT0 0171.9FALSE00
2026-05-15150PUT0 66161.43FALSE00
2026-05-15160PUT0 0151.66FALSE00
2026-05-15170PUT0 9142.48FALSE00
2026-05-15180PUT0 0133.84FALSE00
2026-05-15190PUT0 0125.66FALSE00
2026-05-15200PUT0 10117.89FALSE00
2026-05-15210PUT0 0110.5FALSE00
2026-05-15220PUT0 0103.44FALSE00
2026-05-15230PUT0 1096.68FALSE00
2026-05-15240PUT0 1590.19FALSE00
2026-05-15250.02PUT0 280083.95FALSE00
2026-05-15260PUT0 6677.93FALSE00
2026-05-15270PUT0 1872.12FALSE00
2026-05-15280PUT0 066.49FALSE00
2026-05-15290PUT0 061.03FALSE00
2026-05-15300PUT0 31855.72FALSE00
2026-05-15310PUT0 050.54FALSE00
2026-05-15320PUT0 045.49FALSE00
2026-05-15330PUT0 540.54FALSE00
2026-05-15340PUT0 035.68FALSE00
2026-05-15350.05PUT0 391230.9FALSE00
2026-05-15360.05PUT0 7226.17FALSE00
2026-05-15370.05PUT0 3421.47FALSE00
2026-05-15380PUT0 1521.1FALSE00
2026-05-15390.1PUT0 3119.02FALSE00
2026-05-15400.18PUT1 3539.48FALSE0.030.2
2026-05-15410PUT0 227.76TRUE00
2026-05-15420PUT0 00TRUE00
2026-05-15430PUT0 040.5TRUE00
2026-05-15440PUT0 246.67TRUE00
2026-05-15454PUT0 032.48TRUE00
2026-05-15460PUT0 059.87TRUE00
2026-05-15470PUT0 065.84TRUE00
2026-05-15480PUT0 068.21TRUE00
2026-05-15490PUT0 073.48TRUE00
2026-05-15500PUT0 082.02TRUE00
2026-05-15550PUT0 079.53TRUE00
2026-05-15600PUT0 088.9TRUE00
2026-06-18330CALL0 053.95TRUE00
2026-06-18340CALL0 049.99TRUE00
2026-06-18350CALL0 00TRUE00
2026-06-18360CALL0 00TRUE00
2026-06-18370CALL0 00TRUE00
2026-06-18380CALL0 00TRUE00
2026-06-18390CALL0 08.62TRUE00
2026-06-18401.1CALL0 1014.38TRUE00
2026-06-18410CALL0 015.14FALSE00
2026-06-18420CALL0 022.01FALSE00
2026-06-18430CALL0 027.67FALSE00
2026-06-18440CALL0 032.68FALSE00
2026-06-18450CALL0 011.96FALSE00
2026-06-18460CALL0 041.5FALSE00
2026-06-18470CALL0 045.47FALSE00
2026-06-18480CALL0 049.23FALSE00
2026-06-18490CALL0 023.36FALSE00
2026-06-18330PUT0 026.41FALSE00
2026-06-18340PUT0 031.23FALSE00
2026-06-18350.05PUT25 022.73FALSE0.050
2026-06-18360PUT0 046.52FALSE00
2026-06-18370PUT0 043.35FALSE00
2026-06-18380PUT0 037.46FALSE00
2026-06-18390PUT0 031.84FALSE00
2026-06-18400PUT0 013.73FALSE00
2026-06-18410PUT0 019.53TRUE00
2026-06-18420PUT0 018.91TRUE00
2026-06-18430PUT0 028.15TRUE00
2026-06-18440PUT0 019.77TRUE00
2026-06-18450PUT0 024.8TRUE00
2026-06-18460PUT0 029.69TRUE00
2026-06-18470PUT0 045.15TRUE00
2026-06-18480PUT0 048.93TRUE00
2026-06-18490PUT0 052.53TRUE00
2026-07-17100CALL0 0194.34TRUE00
2026-07-17120CALL0 2169.08TRUE00
2026-07-17130CALL0 1171.79TRUE00
2026-07-17140CALL0 0158.1TRUE00
2026-07-17150CALL0 0119.08TRUE00
2026-07-17160CALL0 0142.22TRUE00
2026-07-17170CALL0 1122.48TRUE00
2026-07-17180CALL0 0125.76TRUE00
2026-07-17190CALL0 0118.27TRUE00
2026-07-17200CALL0 36111.19TRUE00
2026-07-17210CALL0 5104.47TRUE00
2026-07-17220CALL0 163.05TRUE00
2026-07-17230CALL0 8557.83TRUE00
2026-07-17240CALL0 652.8TRUE00
2026-07-172516.04CALL0 882.4TRUE00
2026-07-17260CALL0 2176.95TRUE00
2026-07-17270CALL0 038.37TRUE00
2026-07-17280CALL0 4266.62TRUE00
2026-07-17290CALL0 058.58TRUE00
2026-07-17300CALL0 656.94TRUE00
2026-07-17310CALL0 153.65TRUE00
2026-07-17320CALL0 149.06TRUE00
2026-07-17330CALL0 20TRUE00
2026-07-17340CALL0 00TRUE00
2026-07-17350CALL0 30TRUE00
2026-07-17360CALL0 00TRUE00
2026-07-17370CALL0 00TRUE00
2026-07-17380CALL0 00TRUE00
2026-07-17390CALL0 00TRUE00
2026-07-17400CALL0 5280TRUE00
2026-07-17410.02CALL8 48090FALSE-0.03-0.6
2026-07-17420CALL0 13.28FALSE00
2026-07-17430CALL0 122.05FALSE00
2026-07-17440CALL0 026.19FALSE00
2026-07-17450CALL0 029.95FALSE00
2026-07-17460CALL0 033.43FALSE00
2026-07-17470CALL0 036.7FALSE00
2026-07-17480CALL0 039.78FALSE00
2026-07-17490CALL0 042.7FALSE00
2026-07-17500CALL0 045.49FALSE00
2026-07-17550CALL0 057.85FALSE00
2026-07-17600CALL0 132.59FALSE00
2026-07-17100PUT0 0117.77FALSE00
2026-07-17120PUT0 0205.76FALSE00
2026-07-17130PUT0 196.68FALSE00
2026-07-17140PUT0 390.76FALSE00
2026-07-17150PUT0 185.27FALSE00
2026-07-17160PUT0 180.13FALSE00
2026-07-17170PUT0 175.31FALSE00
2026-07-17180PUT0 370.77FALSE00
2026-07-17190PUT0 1266.47FALSE00
2026-07-17200PUT0 6662.4FALSE00
2026-07-17210PUT0 1958.51FALSE00
2026-07-17220PUT0 3554.81FALSE00
2026-07-17230PUT0 10456.3FALSE00
2026-07-17240PUT0 4352.61FALSE00
2026-07-17250PUT0 17452.22FALSE00
2026-07-17260PUT0 248.62FALSE00
2026-07-17270PUT0 047.41FALSE00
2026-07-17280PUT0 743.89FALSE00
2026-07-17290PUT0 140.48FALSE00
2026-07-17300.05PUT206 158032.98FALSE0.050
2026-07-17310PUT0 1036.79FALSE00
2026-07-17320PUT0 234.58FALSE00
2026-07-17330PUT0 531.19FALSE00
2026-07-17340PUT0 128.78FALSE00
2026-07-17350.05PUT0 43820.32FALSE00
2026-07-17360PUT0 3222.06FALSE00
2026-07-17370PUT0 7016.47FALSE00
2026-07-17380PUT0 517.53FALSE00
2026-07-17390.1PUT0 5514.66FALSE00
2026-07-17400.15PUT0 39310.9FALSE00
2026-07-17410.25PUT0 1077.25TRUE00
2026-07-17420PUT0 016.14TRUE00
2026-07-17430PUT0 015.67TRUE00
2026-07-17440PUT0 018.09TRUE00
2026-07-17450PUT0 121.87TRUE00
2026-07-17460PUT0 026.41TRUE00
2026-07-17470PUT0 038TRUE00
2026-07-17480PUT0 041.15TRUE00
2026-07-17490PUT0 043.32TRUE00
2026-07-17500PUT0 040.66TRUE00
2026-07-17550PUT0 058.9TRUE00
2026-07-17600PUT0 067.66TRUE00
2026-10-16100CALL0 0127.4TRUE00
2026-10-16120CALL0 0109.5TRUE00
2026-10-16130CALL0 0101.76TRUE00
2026-10-16140CALL0 094.64TRUE00
2026-10-16150CALL0 088.06TRUE00
2026-10-16160CALL0 081.93TRUE00
2026-10-16170CALL0 076.2TRUE00
2026-10-16180CALL0 070.81TRUE00
2026-10-16190CALL0 065.72TRUE00
2026-10-16200CALL0 468.24TRUE00
2026-10-16210CALL0 063.57TRUE00
2026-10-16220CALL0 059.13TRUE00
2026-10-16230CALL0 054.89TRUE00
2026-10-16240CALL0 350.85TRUE00
2026-10-16250CALL0 046.98TRUE00
2026-10-16260CALL0 043.27TRUE00
2026-10-16270CALL0 039.71TRUE00
2026-10-16280CALL0 1242.45TRUE00
2026-10-16290CALL0 132.98TRUE00
2026-10-16300CALL0 131.48TRUE00
2026-10-16310CALL0 00TRUE00
2026-10-16320CALL0 00TRUE00
2026-10-16330CALL0 00TRUE00
2026-10-16340CALL0 00TRUE00
2026-10-16350CALL0 118.23TRUE00
2026-10-16360CALL0 00TRUE00
2026-10-16370CALL0 00TRUE00
2026-10-16380CALL0 00TRUE00
2026-10-16390CALL0 00TRUE00
2026-10-16400CALL0 300TRUE00
2026-10-16410.1CALL0 45590FALSE00
2026-10-16420.05CALL0 510.7FALSE00
2026-10-16430CALL0 014.17FALSE00
2026-10-16440CALL0 017.17FALSE00
2026-10-16450CALL0 07.59FALSE00
2026-10-16460CALL0 022.36FALSE00
2026-10-16470CALL0 024.69FALSE00
2026-10-16480CALL0 026.87FALSE00
2026-10-16490CALL0 028.94FALSE00
2026-10-16500CALL0 030.92FALSE00
2026-10-16550CALL0 039.64FALSE00
2026-10-16600CALL0 022.3FALSE00
2026-10-16100PUT0 082.83FALSE00
2026-10-16120PUT0 0144.77FALSE00
2026-10-16130PUT0 068.08FALSE00
2026-10-16140PUT0 093.89FALSE00
2026-10-16150PUT0 460.1FALSE00
2026-10-16160PUT0 078.7FALSE00
2026-10-16170PUT0 553.14FALSE00
2026-10-16180PUT0 054.66FALSE00
2026-10-16190PUT0 351.41FALSE00
2026-10-16200PUT0 048.32FALSE00
2026-10-16210PUT0 145.38FALSE00
2026-10-16220PUT0 042.57FALSE00
2026-10-16230PUT0 342.4FALSE00
2026-10-16240PUT0 072.29FALSE00
2026-10-16250PUT0 4137.07FALSE00
2026-10-16260PUT0 036.26FALSE00
2026-10-16270PUT0 035.11FALSE00
2026-10-16280PUT0 033.74FALSE00
2026-10-16290PUT0 052.71FALSE00
2026-10-16300PUT0 930.56FALSE00
2026-10-16310PUT0 045.65FALSE00
2026-10-16320PUT0 041.86FALSE00
2026-10-16330PUT0 038.52FALSE00
2026-10-16340PUT0 035.22FALSE00
2026-10-16350PUT0 15118.45FALSE00
2026-10-16360PUT0 015.56FALSE00
2026-10-16370PUT0 025.47FALSE00
2026-10-16380PUT0 011.44FALSE00
2026-10-16390PUT0 09.02FALSE00
2026-10-16400PUT0 415.52FALSE00
2026-10-16410PUT0 07.69TRUE00
2026-10-16420PUT0 012.2TRUE00
2026-10-16430PUT0 013.09TRUE00
2026-10-16440PUT0 014.81TRUE00
2026-10-16450PUT0 017.01TRUE00
2026-10-16460PUT0 020.67TRUE00
2026-10-16470PUT0 022.93TRUE00
2026-10-16480PUT0 025.07TRUE00
2026-10-16490PUT0 027.11TRUE00
2026-10-16500PUT0 028.3TRUE00
2026-10-16550PUT0 043.02TRUE00
2026-10-16600PUT0 050.24TRUE00
2027-01-1550CALL0 0159.88TRUE00
2027-01-15100CALL0 17101.76TRUE00
2027-01-15130CALL0 079.5TRUE00
2027-01-15150CALL0 51972.82TRUE00
2027-01-15180CALL0 151.6TRUE00
2027-01-15200CALL0 5050.84TRUE00
2027-01-15230CALL0 7538.81TRUE00
2027-01-15250CALL0 5031.27TRUE00
2027-01-15280CALL0 38731.32TRUE00
2027-01-15300CALL0 2020TRUE00
2027-01-15330CALL0 30TRUE00
2027-01-15350CALL0 25580TRUE00
2027-01-15370CALL0 10TRUE00
2027-01-15401.07CALL0 12850TRUE00
2027-01-15420.05CALL1 33760FALSE0.020.67
2027-01-15450CALL0 496.02FALSE00
2027-01-15470CALL0 119.26FALSE00
2027-01-15500.01CALL0 5010.78FALSE00
2027-01-15550CALL0 60913.97FALSE00
2027-01-15600CALL0 017.74FALSE00
2027-01-1550PUT0 0100.45FALSE00
2027-01-15100PUT0 767.78FALSE00
2027-01-15130PUT0 055.78FALSE00
2027-01-15150PUT0 38949.29FALSE00
2027-01-15180PUT0 1141.04FALSE00
2027-01-15200PUT0 19939.74FALSE00
2027-01-15230PUT0 236.61FALSE00
2027-01-15250.05PUT0 77528.76FALSE00
2027-01-15280PUT0 928.83FALSE00
2027-01-15300.05PUT13 59719.64FALSE0.020.67
2027-01-15330PUT0 524.05FALSE00
2027-01-15350PUT0 65015.06FALSE00
2027-01-15370.05PUT0 4317.59FALSE00
2027-01-15400.15PUT20 7295.27FALSE0.050.5
2027-01-15420PUT0 170TRUE00
2027-01-15450PUT0 013.05TRUE00
2027-01-15470PUT0 117.85TRUE00
2027-01-15500PUT0 023.63TRUE00
2027-01-15550PUT0 033.1TRUE00
2027-01-15600PUT0 038.87TRUE00
2028-01-2130CALL0 095.55TRUE00
2028-01-2150CALL0 00TRUE00
2028-01-21100CALL0 30TRUE00
2028-01-21130CALL0 30TRUE00
2028-01-21150CALL0 00TRUE00
2028-01-21180CALL0 10TRUE00
2028-01-212020.9CALL0 70TRUE00
2028-01-21220CALL0 00TRUE00
2028-01-21250CALL0 20TRUE00
2028-01-21270CALL0 20TRUE00
2028-01-21300CALL0 20TRUE00
2028-01-21327.1CALL0 190TRUE00
2028-01-21355.78CALL0 7850TRUE00
2028-01-21370CALL0 00TRUE00
2028-01-21401.05CALL0 9390TRUE00
2028-01-21420CALL0 100FALSE00
2028-01-21450.05CALL0 4101.51FALSE00
2028-01-21470CALL0 03.87FALSE00
2028-01-21500CALL0 020.99FALSE00
2028-01-21550CALL0 026.47FALSE00
2028-01-21600.1CALL0 211.52FALSE00
2028-01-2130PUT0 082.71FALSE00
2028-01-2150PUT0 066.23FALSE00
2028-01-21100PUT0 049.08FALSE00
2028-01-21130PUT0 040.6FALSE00
2028-01-21150PUT0 2536.02FALSE00
2028-01-21180PUT0 2030.22FALSE00
2028-01-21200PUT0 029.81FALSE00
2028-01-21220PUT0 525.31FALSE00
2028-01-21250PUT0 024.35FALSE00
2028-01-21270PUT0 821.99FALSE00
2028-01-21300.05PUT50 8613.86FALSE0.050
2028-01-21320PUT0 914.3FALSE00
2028-01-21350.05PUT0 2928.34FALSE00
2028-01-21370.15PUT1 1088.39FALSE0.150
2028-01-21400.2PUT388 14575.07FALSE0.050.33
2028-01-21421.3PUT0 5413.32TRUE00
2028-01-21450PUT0 00TRUE00
2028-01-21470PUT0 014.87TRUE00
2028-01-21500PUT0 018.07TRUE00
2028-01-21550PUT0 022.68TRUE00
2028-01-21600PUT0 028.82TRUE00

Latest APLS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$39.4
Jun 13, 2022 7:59 PM EST25$39.4
Jun 13, 2022 7:59 PM EST86$39.39
Jun 13, 2022 7:59 PM EST14$39.4
Jun 13, 2022 7:59 PM EST32$39.4

Apellis Pharmaceuticals, Inc (APLS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000083423720004741/0000834237-20-004741-index.htm
2020-02-053/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320003295/0000899243-20-003295-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320008068/0000899243-20-008068-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027595/0000899243-20-027595-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027598/0000899243-20-027598-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090221920000352/0000902219-20-000352-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090266420001196/0000902664-20-001196-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000092963820000336/0000929638-20-000336-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013334/0001127602-20-013334-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013338/0001127602-20-013338-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-04-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014554/0001127602-20-014554-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-06-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019258/0001127602-20-019258-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052855/0001193125-20-052855-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052867/0001193125-20-052867-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520098977/0001193125-20-098977-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115068/0001193125-20-115068-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115084/0001193125-20-115084-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520135621/0001193125-20-135621-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520141579/0001193125-20-141579-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520157384/0001193125-20-157384-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520277496/0001193125-20-277496-index.htm
2010-05-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1492242/000149224210000001/0001492242-10-000001-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1492422/000156459020007350/0001564590-20-007350-index.htm
2020-04-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020019689/0001564590-20-019689-index.htm
2020-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020034763/0001564590-20-034763-index.htm
2020-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020049423/0001564590-20-049423-index.htm
2020-08-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1492422/999999999720004458/9999999997-20-004458-index.htm

Apellis Pharmaceuticals, Inc (APLS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apellis Pharmaceuticals, Inc (APLS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2117%
Institutional Ownership: 8285%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-13Pascal DeschateletsChief Operating OfficerSell55,398.0040.982,270,154.641,008,681.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell5,000.0040.67203,330.001,027,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell30,637.0040.661,245,792.331,032,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell300.0023.867,158.001,053,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell3,212.0022.2871,556.941,053,367.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell15,065.0021.58325,087.641,056,579.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-02-19Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,058,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,063,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-13Pascal DeschateletsChief Operating OfficerBuy117,205.002.14250,818.701,064,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-10Cedric FrancoisChief Executive OfficerBuy34,375.001,066,805.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell12,060.0020.69249,557.581,071,644.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-10-15Cedric FrancoisChief Executive OfficerSell5,000.0034.46172,300.001,083,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-03-17Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell700.0022.2915,600.201,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,192.0021.5747,279.251,084,404.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,108.0020.7343,694.621,086,596.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-09-15Cedric FrancoisChief Executive OfficerSell5,000.0030.96154,800.001,088,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,088,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-08-20Cedric FrancoisChief Executive OfficerSell3,457.0030.00103,710.001,093,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-08-18Cedric FrancoisChief Executive OfficerSell1,543.0030.0046,290.001,096,536.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-07-15Cedric FrancoisChief Executive OfficerSell5,000.0032.12160,600.001,098,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-06-15Cedric FrancoisChief Executive OfficerSell5,000.0030.21151,050.001,103,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-05-15Cedric FrancoisChief Executive OfficerSell5,000.0029.92149,600.001,108,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-04-15Cedric FrancoisChief Executive OfficerSell5,000.0029.77148,850.001,113,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-02-10LUKAS SCHEIBLEROfficerBuy9,375.0012,310.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-10-07Victoria L. BrownProgram Team LeadBuy12,000.0018.98227,760.0015,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10Timothy Eugene SullivanChief Financial OfficerBuy11,688.0023,387.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-10Nicole D PerryVice President - FinanceBuy2,500.002,500.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-10Ahmad SadrOfficerBuy2,725.002,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-11-02Federico GrossiCHIEF MEDICAL OFFICERSell600.0031.0918,654.0027,725.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-10-01Federico GrossiOfficerSell600.0030.2218,132.0028,325.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-09-01Federico GrossiOfficerSell600.0031.5818,948.0028,925.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-08-03Federico GrossiOfficerSell600.0026.2815,768.0029,525.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-07-01Federico GrossiOfficerSell850.0032.4327,565.5030,125.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-06-15Federico GrossiOfficerSell856.0030.2125,859.7630,975.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-02-10Federico GrossiOfficerBuy9,375.0031,831.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-10David O. WatsonGeneral CounselSell5,000.0044.50222,500.0035,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-10-07Victoria L. BrownProgram Team LeadSell12,000.0035.00420,000.003,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10David O. WatsonGeneral CounselBuy6,375.0040,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-10David O. WatsonGeneral CounselBuy7,505.002.6720,038.3542,922.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-05-08PAUL R. FONTEYNEDirectorBuy5,000.0031.81159,034.005,000.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-02-10Lucia CelonaOfficerBuy5,213.005,213.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-14Alec MachielsDirectorSell2,500.0042.35105,875.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorSell2,500.0030.2175,525.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-07Alec MachielsDirectorSell7,500.0035.00262,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-15Alec MachielsDirectorSell2,500.0035.0087,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-02-14Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-10-07Alec MachielsDirectorBuy7,500.002.6720,025.00677,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-02-10Thomas A. LacknerOfficerBuy2,725.007,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-10Pascal DeschateletsChief Operating OfficerBuy9,375.00891,118.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-10Adam J. TownsendOfficerBuy9,375.009,375.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerSell52,075.0042.802,228,966.23946,874.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerBuy117,206.002.14250,820.84998,949.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm